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A rat model of complete 
atrioventricular block recapitulates 
clinical indices of bradycardia and 
provides a platform to test disease-
modifying therapies
Nam Kyun Kim1,3, David Wolfson2, Natasha Fernandez1, Minji shin1 & Hee Cheol Cho1,2
Complete atrioventricular block (CAVB) is a life-threatening arrhythmia. A small animal model of 
chronic CAVB that properly reflects clinical indices of bradycardia would accelerate the understanding 
of disease progression and pathophysiology, and the development of therapeutic strategies. We sought 
to develop a surgical model of CAVB in adult rats, which could recapitulate structural remodeling and 
arrhythmogenicity expected in chronic CAVB. Upon right thoracotomy, we delivered electrosurgical 
energy subepicardially via a thin needle into the atrioventricular node (AVN) region of adult rats to 
create complete AV block. the chronic CAVB animals developed dilated and hypertrophied ventricles 
with preserved systolic functions due to compensatory hemodynamic remodeling. Ventricular 
tachyarrhythmias, which are difficult to induce in the healthy rodent heart, could be induced 
upon programmed electrical stimulation in chronic CAVB rats and worsened when combined with 
β-adrenergic stimulation. Focal somatic gene transfer of TBX18 to the left ventricular apex in the CAVB 
rats resulted in ectopic ventricular beats within days, achieving a de novo ventricular rate faster than 
the slow atrioventricular (AV) junctional escape rhythm observed in control CAVB animals. The model 
offers new opportunities to test therapeutic approaches to treat chronic and severe CAVB which have 
previously only been testable in large animal models.
Complete atrioventricular block (CAVB) is a major cardiac conduction disorder, in which the transmission of 
an electrical impulse from the atria to the ventricles is completely inhibited1–3. The subsequent slow AV junc-
tional escape rhythm is inadequate to support CAVB patients’ hemodynamic needs, requiring the implantation 
of an electronic pacemaker device4,5. If left untreated, the ventricles of CAVB patients are susceptible to spon-
taneous and drug-induced QT prolongation6,7, which often precipitates to life-threatening arrhythmias such as 
torsades de pointes8–10. An animal model of CAVB would be ideal for studies aimed at understanding mech-
anisms of catastrophic ventricular tachyarrhythmias11, as well as developing therapies to mitigate arrhythmo-
genic events in CAVB12,13. We and others have developed large animal models of CAVB12,14–17, but those models 
are resource-exhausting and not widely available for standard benchtop research. Transgenic mouse models can 
exhibit spontaneous AV block18,19, but their degree and persistence of AV block are unpredictable, as CAVB is an 
adverse side effect of the transgene modification rather than a direct effect. Surgical models of CAVB have been 
documented in rodents20–23. However, we found these methods difficult to reproduce and adopt independently. 
One approach of injecting 70% ethanol into the AVN20,24, is hindered by a limited number of ablation attempts, 
as repeated doses of alcohol lead to global heart dysfunction and systemic complications, thus reducing survival. 
Other approaches require the use of custom-engineered, rodent-sized radiofrequency (RF) ablation catheters22,23, 
impeding widespread implementation in conventional laboratories.
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We sought to develop a rodent model of CAVB that requires only a routine set of surgical instrumentation, 
yields a high success rate in 6-month old female rats, persists long-term (4 weeks), and recapitulates ventricular 
arrhythmias that are often manifested in CAVB patients25. Here, we present a long-term survival CAVB model 
in rats achieved via subepicardial delivery of electrosurgical energy into, and the subsequent fibrosis of, the AVN 
region. CAVB was achieved immediately upon ablation of the AVN and was stable for >4 weeks. The CAVB 
animals exhibited electrical abnormalities, including spontaneous and inducible ventricular tachyarrhythmias, 
and progressive ventricular remodeling, evidenced by increased stroke volume and ventricular hypertrophy with 
preserved ejection fraction at week 4. Notably, our chronic CAVB model revealed striking age and sex differences 
in survival rates, in which all males and 3-month old females died within the first 72 hours of creating CAVB, 
suggesting that the slow junctional escape rhythm is insufficient for supporting male and 3-month old female rats.
We also sought to reverse the severe CAVB-induced ventricular bradycardia by focal somatic gene transfer 
of TBX18, a concept we have previously demonstrated for converting chamber cardiomyocytes to induced pace-
maker cells12,26,27. Direct intramyocardial delivery of TBX18 into the left ventricular apex of chronic CAVB rats 
revealed emergence of ectopic ventricular beats at a rate higher than the slow AV junctional rhythm of the con-
trol animals. The TBX18-induced ventricular pacing is the first demonstration of the technique’s feasibility and 
disease-modifying potential, when the biologic is delivered after chronic CAVB had been established.
Results
Design of a custom, epicardial electrical ablation system. We attempted to disrupt AVN conduction 
by focal ablation with electrical energy. We elected to use an electrosurgical unit over electrocautery, because 
electrosurgery delivers high-frequency electrical energy, traveling beyond the tissue-electrode contact site. On the 
other hand, electrocautery, which delivers heat only, is limited to burning tissues at the contact site. Initial trials of 
electrical energy delivery by direct contact of an electrosurgical pen on the AVN region caused an epicardial scar 
that remained largely superficial. This failed to generate reproducible CAVB. In order to deliver electrical energy 
subepicardially, we employed a thin needle of a 0.3 mm diameter (Fig. 1A). This needle was advanced through 
the epicardium into the AVN region, and was used as a conduit to deliver electrical energy to the AVN tissue. 
We also hypothesized that epicardial electrograms from the needle tip would show a sharp intracardiac potential 
wave which would be manifested near the P-wave if the needle entry was in proximity to the AVN. To test this, 
the ablation needle was coupled to a surface ECG electrode by wrapping them together with a polytetrafluoroeth-
ylene tape (Fig. 1B). This design enabled real-time monitoring of epicardial electrograms as the distal end of the 
ablation needle makes an entry into the AVN region (Fig. 1C,D). The distal end of the ablation needle was bent 
at 3 mm from the sharp end to control the depth of the needle entry (Fig. 1B), thereby preventing perforation to 
the surrounding myocardium and aorta. We determined the entry site of the ablation needle to the AVN area by 
the characteristic fat pad landmark consistently located between the aortic root and the medial wall of the right 
atrium (Fig. 1D,E, Supplemental video 1).
Electrosurgical AVN ablation leads to stable CAVB in 6-month old female rats. The following 
steps were taken prior to delivering electrosurgical energy: The bent distal tip of the ablation needle was advanced 
into the epicardial surface, posterior to the fat pad and posterolateral of the aorta, and pointing toward the left 
ventricular apex. This maneuver often elicited skipped ventricular beats, transient AV dissociations indicative of 
mechanical disruption of AVN or high His bundle conduction, and/or premature ventricular complexes (PVCs) 
(Fig. 2A,B and Table 1). Parallel to the surface ECGs, real-time epicardial electrograms at the needle insertion site 
revealed sharp depolarizations starting within the P-waves of the surface ECG (Fig. 2C). Electrosurgical energy 
was delivered upon satisfying these three criteria: (i) anatomical identification of the AVN fat pad, (ii) transient 
ventricular arrhythmias elicited by advancing and maneuvering the ablation needle, and (iii) sharp deflections 
on epicardial electrograms that coincided with P waves on the surface ECG (Supplemental video 2). An ablation 
power of 2 Watts was delivered for at most 60 seconds (Table 2). If stable CAVB was not observed after initial 
ablation, the power was increased to 3 Watts and ablation repeated for less than 10 seconds. After the second 
energy delivery, if persistent CAVB was still not observed, the needle was carefully retracted, repositioned to a 
new site matching the three criteria above, and the electrosurgical energy delivery was repeated. Successful CAVB 
induction was evidenced by complete dissociation of the QRS complexes from the P waves on bipolar limb leads 
(Fig. 2D). The thoracotomy was repaired when the CAVB was stable for 10–15 minutes. Histological examination 
of the AV junctional region 4 weeks after CAVB shows extensive fibrosis that left little viable myocardium in the 
AV junctional region (Fig. 3B–E, representative histology sections from four CAVB animals). Upon ablation of 
the AVN, the heart rate of adult female rats dropped immediately from a normal sinus rhythm of 351 ± 40 bpm 
to a junctional escape rhythm of 113 ± 37 bpm (n = 21). Fifteen out of the 21 (73%) 6-month old female rats were 
viable for ≥4 weeks with a stable CAVB (Fig. 4A). Three animals suffered sudden death soon after the survival 
surgery and one recovered from CAVB to 1° AV block. The mean junctional escape rhythm was stable throughout 
the 4 week follow-up at 122 ± 19 to 114 ± 22 bpm at week 1 to week 4 (Table 3).
Male rats and 3-month old female rats are not viable after CAVB. Age-matched, 6-month old male 
rats were not viable after CAVB, all expiring within 3 days after the surgery (n = 4 rats). Immediately upon CAVB, 
the ventricular rate of the 6-month old male rats was 106 ± 15 bpm, statistically similar to that of the 6-month old 
female rats at 123 ± 39 bpm (p = 0.49). However, the male rats weighed significantly more at 504 ± 15 g compared to 
the age-matched female rats weighing 372 ± 63 g (p < 0.05, Table 4). We performed CAVB on 3-month old male rats 
(n = 5 rats) size-matched to the 6-month old female rats, but all five 3-month old male rats expired as well within a 
day of creating CAVB. The ventricular escape rate upon CAVB induction was significantly slower in the 3-month 
old male rats at 65 ± 9 bpm than the 6-month old males (106 ± 15 bpm, p < 0.05). We asked if the mortality in the 
males was strictly due to sex difference, and performed CAVB in 3-month old female rats weighing 271 ± 16 g. The 
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3 month old female rats also expired in 72 hours after CAVB induction (Fig. 4A), exhibiting a mean ventricular rate 
of 84 ± 7 bpm (n = 4 rats), that was statistically higher than the age-matched 3-month old male rats (65 ± 9 bpm, 
p < 0.05), but slower than the 6-month old female rats (123 ± 39 bpm, p < 0.05). Subcutaneous injection of isopro-
terenol during the post-op recovery period transiently increased the slow junctional rhythm of the 3-month old 
animals, but did not aid in the survival of those animals beyond three days post-op. To learn if the differences in the 
acute survival rates CAVB animals may be due to developmental stages rather than to sex difference per se, we exam-
ined the normal compact AVN areas near the central fibrous body of 6-month old female rats, 6-month old male 
rats, 3-month old female rats, and 3-month old male rats (n = 3 for each group). The compact AVN region near the 
central fibrous body was distinctively smaller in the 3-month old rats of both sexes compared to that of the 6-month 
old rats (Fig. 4B,C). In female rats, the mean area of the compact AV node was 0.057 ± 0.020 mm2 in 3-month old, 
compared to 0.173 ± 0.026 mm2 in 6-months old females (n = 3 rats, p < 0.05). Likewise in male rats, the mean 
area of the AVN was 0.052 ± 0.028 mm2 in 3-month old, compared to 0.177 ± 0.034 mm2 in 6-month old males 
(n = 3 rats, p < 0.05). No significant difference was found in AVN area between age-matched male and female rats 
(Fig. 4C). These anatomical differences between the 3-month old and 6-month old rats are in line with the gradual 
postnatal expansion of the AVN region in humans28.
Figure 1. Design of electrosurgical needle ablation of the AV node. (A) An acupuncture needle and an 
ECG needle electrode, placed together to form a single unit to deliver electrosurgical energy and to record 
electrogram at the needle entry site. (B) The ablation needle and an ECG needle was assembled together with a 
polytetrafluoroethylene tape which also provides electrical insulation. The sharp end of the needle was bent at 
3–4 mm from the end to limit the needle entry. (C) Illustration of the ablation needle, electrosurgical pen contact 
site, and the ECG electrodes during CAVB procedure. The intracardiac electrogram is recorded from the needle 
entry site (orange colored negative electrode) to left leg (orange colored positive electrode). (D) Needle entry is 
made through the anatomical landmark, fat pad, pointing toward the LV apex. (E) A photograph of the fat pad 
near the aortic root upon retracting the right atrial appendage.
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Chronic CAVB leads to ventricular remodeling and increased arrhythmogenicity. Unresolved, 
severe ventricular bradycardia is known to trigger compensatory ventricular remodeling and increased 
arrhythmogenicity6,8,9,23. We performed echocardiographic examinations over a 4-week follow-up period in 
CAVB animals and compared the data with sham-operated animals which underwent the same surgical proce-
dures as the CAVB animals, including thoracotomy and advancement of the ablation needle but without deliver-
ing the ablative energy. Parasternal short axis view and M-mode echocardiograms at baseline just prior to CAVB 
induction (Fig. 5A) and four weeks after CAVB (Fig. 5B) in the same rat illustrates severely enlarged left ventricle 
at 4-week. As expected, the sham-operated animals (n = 5) showed no changes in interventricular septum (IVS) 
or left ventricular posterior wall (LVPW) dimensions at systole or diastole over the four-week follow-up period. 
Similarly, CAVB animals (n = 6) showed no significant changes from the baseline measurements to 1- and 4-week 
Figure 2. Surface and epicardial electrocardiograms before and after CAVB creation. (A) An example of surface 
ECG and simultaneous recording of epicardial electrogram under normal sinus rhythm. (B) Typical transient 
ventricular arrhythmias that could be observed during needle entry into the AVN region. (C) Upon the 
needle entry into the proper AVN region, sharp depolarizations starting within the P-wave from the epicardial 
electrode can be observed from the subepicardial electrogram. Upon successful CAVB, the His-like potentials 
are no longer observed. (D) Long-term follow-up of the CAVB animals demonstrate stable and complete heart 
block for at least 4 weeks.
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after CAVB in IVS or LVPW dimensions although the measurements showed higher trend compared to those of 
the sham-operated animals at 1- and 4-week time points (Fig. 5C,D). In contrast, left ventricular internal diam-
eter (LVID) at systole increased at 4-week and diastolic LVID increased at 1-week and further more at 4-week 
in CAVB animals while those of the sham-operated rats remained the same (Fig. 5E). The increases in the LVID 
led to parallel increases in the end-diastolic and end-systolic left ventricular volumes (LVEDV and LVESV) over 
time in CAVB animals (Fig. 5F). Left ventricular stroke volume increased by >2-fold in CAVB animals at week 4 
compared to baseline and to sham controls (p < 0.05, Fig. 5G). The LV ejection fraction and fractional shortening 
(LVEF and LVFS) increased transiently at 1 week after the surgery, but returned to the baseline levels by week 4 
(Fig. 5H). The structural remodeling resulted in increased left ventricular mass by 299 ± 195 mg at week 1 and by 
350 ± 94 mg at week 4 from the baseline LV mass of 542 ± 74 mg (Fig. 5I). All reported masses were approximated 
using echocardiography measurements. These results demonstrate that compensatory left ventricular remodeling 
ensues as the severe ventricular bradycardia transitions to a chronic condition in CAVB rats.
We examined for spontaneous ventricular arrhythmias by implanting an ECG telemetry device in three of 
the 6-month old female CAVB rats by 24/7 ambulatory telemetry. Spontaneous ventricular arrhythmias such as 
non-sustained ventricular tachyarrhythmias (NSVT) or PVCs (Fig. 5J,K) were observed in one of three CAVB 
rats two days after the AVN ablation. PVCs were more pronounced during the first two days after CAVB and 
resolved in 3–4 days. We examined arrhythmia inducibility with programmed electrical stimulation (PES) at 
week 4 after creating CAVB. PES elicited self-terminating, non-sustained VTs in 4 out of 5 CAVB animals. Upon 
administration of a β-adrenergic agonist, isoproterenol, PES-induced arrhythmias precipitated into sustained VT 
and/or ventricular fibrillation (VF) in the same four animals that initially exhibited non-sustained VT with PES 
only (Fig. 5M,N). The one animal that did not show VT upon PES alone degenerated to non-sustained VT when 
PES was performed upon i.p. injection of isoproterenol (5 mg/kg body weight). Sham-operated animals could 
not be induced into arrhythmia upon PES (Fig. 5M, upper panel). Upon injection of isoproterenol, PES led to 
non-sustained VT in 1/5 and sustained VT in another 1/5 sham-operated animal (Fig. 5M, lower panel). These 
data indicate that CAVB increases susceptibility to ventricular arrhythmias in rats that are resistant to arrhyth-
mias under normal heart function29,30.
the CAVB model uncovers emergence of a distinct ventricular pacing rate induced by direct 
myocardial gene transfer of TBX18 in vivo. We have previously demonstrated that re-expression of 
an embryonic transcription factor, TBX18, converts chamber cardiomyocytes to induced-pacemaker cells12,26,27. 
Focal delivery of TBX18 into the ventricular myocardium gave rise to ectopic ventricular beats in both small27 
and large12 animal models, providing evidence for a transcription factor-based biological pacemaker. Although 
our porcine model of CAVB closely mimicked clinical CAVB12,31, our previous small animal model of ventricu-
lar bradycardia relied on transient AV dissociation resulting from non-specific, cholinergic suppression of AV 
conduction in anesthetized rodents27,32. Using the current rat model of chronic CAVB, we focally delivered an 
adenoviral vector expressing TBX18 (Adeno-TBX18) into the left ventricular apex of 6-month old female rats 
upon confirming stable and complete AV block at 1 week after ablation surgery (Fig. 6A). When the heart rates 
from the ambulatory CAVB animals were averaged each day, the TBX18-injected animals exhibited a mean heart 
rate that trended higher than the ventricular rate of the GFP (Adeno-GFP) control animals (n = 4 for control and 
for TBX18-injected group, Fig. 6B) throughout the 2 week study period. The heart rate fluctuated widely within 
a given 24 hour analysis window, contributing to the large standard deviations in both groups (Fig. 6B, shaded 
areas). Closer examination of the telemetry data indicated that the control, Adeno-GFP injected CAVB ani-
mals’ ECGs were fairly uniform, with slow junctional rhythm pacing the ventricles. In contrast, TBX18-injected 
animals showed episodes of faster ventricular rhythm and PVCs that appeared to be competing with the slow 
junctional rhythm (Fig. 6C). To quantify the distribution of ventricular beating rates, we plotted beating rate his-
tograms upon creating CAVB (Supplementary Fig. 1F), and then after delivering either GFP or TBX18 (Fig. 6D). 
Type of ventricular arrhythmias
Number of animals presenting the 
arrhythmias with some animals presenting 
more than one type of arrhythmias
Premature ventricular complexes (PVCs) 16/30
Skipped beats 11/30
Spontaneous AV dissociations 5/30
Table 1. Spontaneous arrhythmias observed during entry of the ablation needle into the AV nodal 
subepicardial region.
Parameters
Procedure time (min) 85 ± 30
Recovery time (min) 23 ± 9
Ablative energy delivered (W) 2–3
Number of ablation attempts 3 ± 2
Estimated blood loss (mL) 0.9 ± 0.6
Table 2. Procedural Outcomes.
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After CAVB, but before the second thoracotomy and gene transfer, the heart rate histogram showed a single-peak 
distribution throughout a 9-day follow-up (n = 3 rats, Supplementary Fig. 1F). A second thoracotomy with 
Adeno-GFP delivery did not alter the heart rate histogram with a single modal heart rate that started at 158 ± 31 
bpm on day 1 after the gene delivery and stabilized at lower ventricular rates of 137 ± 26, 137 ± 31, and 135 ± 34 
bpm on days 7, 9, and 11 respectively (n = 4 rats, Fig. 6D top). Interestingly on day 4 after Adeno-GFP delivery, 
the heart rate histogram contained a small bimodal distribution but is not present in later time points. In contrast, 
Figure 3. Extensive fibrosis in the AV nodal region 4 weeks after CAVB creation in 6-month old female rats. 
Masson’s Trichrome staining of the AVN area showing an increased presence of fibrotic tissue, (B to E, solid 
line) following CAVB surgery in four 6-months old female rats. The ablation site reveals extensive fibrosis 
compare with the normal rat heart (A, solid line) at 4-weeks post-CAVB creation procedure. The rats were 
6-month old at the time of ablation and exhibited stable CAVB for 4-weeks post-surgery. (A) Histologic finding 
of healthy 6-months old female rat’s AV nodal area. (B–E) Representative histology 4-weeks post-ablation from 
4 separate rats. The mean area of fibrotic region was 0.98 ± 0.15 mm2. MV, mitral valve; TV, tricuspid valve; IVS, 
interventricular septum.
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the heart rate histograms from TBX18-injected animals (TBX18) resolved two distinct peaks in the heart rates 
that lasted beyond 1 week post-delivery; one peak at a rate similar to the slow junctional rhythm of the control 
animals, and a second peak at a faster ventricular rate (n = 4 rats, Fig. 6D, bottom). We posit that the faster ven-
tricular beats originated from the TBX18-injected site while the slow junctional rate originated from the His 
Figure 4. The 3-month old rats’ poor survival upon CAVB correlates with their relatively smaller compact AV 
nodal region. (A) Event-free survival curve of the CAVB rats illustrates the poor survival rates of the 3-month 
old rats and 6-month old male rats. (B) Representative images from the normal AVN region (solid line) of 
male and female rats at 3-month or 6-month of age. Compact nodal region adjacent to the central fibrous 
body is demarcated with a black line in an inset on the left of the arrow. (C) Mean area of the AV nodal region 
was similar between males and females within the same age group, but was significantly larger in 6-month old 
animals compared to 3-month old rats. CF, central fibrous body; IAS, interatrial septum; IVS, interventricular 
septum; MV, mitral valve; TV, tricuspid valve.
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bundle. We recorded 6-lead surface ECGs under anesthesia to examine the cardiac axis of ventricular propaga-
tion. The slow junctional rhythm from Adeno-GFP injected animals corresponded to antegrade conduction on 
vector cardiogram analysis (Fig. 6E, left panels). In contrast, ventricular beats in TBX18-injected rats resulted 
in retrograde conduction, which is in line with de novo biological pacing at the left ventricular apex (Fig. 6E, 
right panels). Additionally, we observed wider QRS complexes in TBX18-injected animals compared to GFP 
control animals, in line with the expected slower ventricular propagation from apical pacing. Thus, our rat model 
of chronic CAVB enabled assessment of the ventricular pacing originating from TBX18-induced pacemakers 
in relation to the intrinsic AV junctional escape rhythm. To reduce invasiveness of two successive thoracoto-
mies, we tested feasibility of replacing the second thoracotomy for gene delivery with echocardiography-guided, 
trans-thoracic injection of biologics. Echo-guided injection of Adeno-mCherry into the left ventricular myocar-
dium of an anesthetized rat generated focal, intramyocardial mCherry expression, negating the need for thora-
cotomy (Supplementary Fig. 1A–E).
Discussion
Previous approaches to creating CAVB in rodents relied on injection of cytotoxic chemicals20,33, use of 
custom-made radiofrequency ablation catheters6,23, or delivering heat by electrocautery to the AVN area20,21. The 
epicardial fat pad served as the anatomical landmark for the AVN region in all those models. However, because 
the location of the AVN can vary significantly from animal to animal34,35, this anatomical landmark alone resulted 
in limited success. We first attempted alcohol ablation of the AVN by direct, intramyocardial delivery of 70% 
ethanol to the AVN region20. This elicited mostly 1° or 2° AV blocks, or a 3° block that spontaneously reverted 
back to normal conduction within a few minutes. Repeat injections of 70% ethanol led to global damage to the 
myocardium, coagulation in the ventricular cavities, and eventual mortality. This method was abandoned.
Our technique delivers high frequency electrical energy via a sharp needle to ablate and necrotize the target 
tissue in a focal manner. We added simultaneous intracardiac recording function33 by attaching an ECG elec-
trode to the proximal end of the ablation needle, which allowed real-time recording of subepicardial electrogram 
as the needle is advanced into the AVN region. This subepicardial electrogram (Fig. 2A, lower panel) revealed 
sharp peaks, which coincided with the P-waves during sinus rhythm but disappeared upon CAVB (Fig. 2C). 
Intracardiac recording of His bundle signals from a bipolar electrode would normally follow the P waves and 
precede the QRS waves6. Thus, the sharp potentials on the epicardial electrogram (Fig. 2C, lower panel) before 
ablation are indicative of electrical potential from AV nodal area.
It is notable that the 6-month old female rats could survive CAVB creation with a slow junctional rate at 
approximately 1/3 of their normal sinus rhythm. In a rabbit model of CAVB, the survival of the animal was 
highly dependent on the implantation of an electronic pacemaker, programmed to pace at >50% of the rabbit’s 
normal sinus rhythm33. In contrast to the hardy female rats, no 6-month old male rats survived the first 72 hours 
post-CAVB creation. We first hypothesized this difference in survival to be due to the male’s larger body weight 
and surface area. To address this, male rats were body weight-matched to the 6-month old female rats, and conse-
quently, were three months younger than the females (93 ± 1 vs. 188 ± 9 days old, respectively). Surprisingly these 
younger, smaller male rats showed a significantly higher mortality rate compared to their older counterparts (0% 
survival in 24 hours), indicating an additional age-dependent effect on mortality. Further investigation showed 
a similarly increased mortality rate in 3-month female rats with CAVB (0% survival in 2.5 days). In both sexes, 
3-month old rats were shown to die of ventricular bradycardia and sudden cardiac arrest (Fig. 5L), leading us to 







Baseline heart rate 352 ± 40 352 ± 40 24
Immediately after CAVB 337 ± 38 102 ± 38
  Male rats 317 ± 31 83 ± 24
   3-month old 333 ± 28 65 ± 9 5
   6-month old 291 ± 15 106 ± 15 4
  Female rats 349 ± 38 113 ± 37
   3-month old 384 ± 24 84 ± 7 4
   6-month old 360 ± 34 123 ± 39 11
1 week after CAVB 357 ± 47 122 ± 19 (females only) 11
4 weeks after CAVB 326 ± 39 114 ± 22 (females only) 8
Table 3. Heart rate change during procedure and follow-up period.
Parameters
Female rats, 
3-month old (n = 4)
Female rats, 
6-month old (n = 11)
Male rats, 3-month 
old (n = 5)
Male rats, 6-month 
old (n = 4)
Age (days) 95 ± 7 188 ± 9 93 ± 1 183 ± 8
Weight (g) 271 ± 16 372 ± 63 352 ± 24 504 ± 15
Table 4. Baseline Characteristics of Each Group.
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Figure 5. Echocardiographic findings before and after CAVB creation. (A) A parasternal short axis view (top) 
and M-mode (bottom) of normal sinus rhythm rat prior to CAVB surgery. (B) A parasternal short axis view 
(top) and M-mode (bottom) of the same rat at one month after CAVB surgery. At one month after CAVB, the left 
ventricle exhibited severe enlargement compared to the baseline. Mean data from 6 rats are analyzed to compare 
hemodynamic functions before and one month after CAVB: systolic and diastolic interventricular septum (C), LV 
posterior wall thickness (D), LV internal diameter (E), LV end systolic volume and end diastolic volume (F), LV stroke 
volume (G), LV ejection fraction and LV fractional shortening (H), LV mass (I). ECG telemetry revealed incidences 
of spontaneous, non-sustained ventricular tachycardia (J) as well as frequent PVCs (K) during first few days after 
CAVB surgery. (L) Representative ECG finding after CAVB creation in 3-month old rats. Following AVN ablation, 
severe ventricular bradycardia was observed (top), followed by non-sustained ventricular tachyarrhythmia (middle), 
and eventually sudden cardiac arrest (bottom). (M) Ventricular arrhythmia inducibility of complete AV block and 
sham-operated rats. In four out of five CAVB rats, programmed electrical stimulation (PES) induced non-sustained 
ventricular tachycardia (VT) which degenerated into sustained, polymorphic VT or ventricular fibrillation (VF) 
upon injection of isoproterenol. In one of the five CAVB rats, VT was induced only when PES was combined with 
isoproterenol injection. Ventricular arrhythmias were inducible in sham-operated animals only upon isoproterenol 
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both sexes of 3-month old rats with CAVB, the ventricular rate was significantly slower (males 65 ± 9 bpm; females 
84 ± 7 bpm), compared to their older 6-month old counterparts (males 106 ± 15 bpm; females 123 ± 39 bpm), 
suggesting that the ventricular conduction system may further develop as the rats age. Our histology data support 
this notion; the compact AVN area of 3-month old rats is much smaller than that of 6-month old rats (Fig. 4B,C). 
In line with our data, the human compact AVN develops extensions towards the high His bundle and under-
goes widening of the transitional cell area in an age-dependent manner28. Younger rat (male and female) hearts 
containing a smaller AV nodal area, have significantly slower ventricular rates than their older counterparts 
following AV ablation. As shown in the ECG data (Fig. 5L), this severe bradycardia is lethal and leads to cardiac 
arrest. Whereas, 6-month old rats have more elongated AV nodal areas and higher ventricular rates following 
ablation, which help to prolong their initial survival. Following CAVB creation, the ventricular rate of 6-month 
old males was comparable to that of the 6-month old females, yet 2 days following ablation, the survival rate of 
male 6-month old CAVB drops significantly. Further investigation and future studies are needed to explain this 
phenomenon. We hypothesize it is due to the lower cardiac index of the larger, heavier male rats compared to 
females; the slow escape rhythm upon CAVB creation is inadequate to sustain the 6-month old male rats due to 
their larger body mass.
Our rat model of chronic CAVB faithfully recapitulated the anticipated disease course involving arrhythmo-
genicity and compensatory hemodynamic remodeling. During the first few days post-op, PVCs and/or skipped 
beats were frequently observed as well as non-sustained ventricular tachyarrhythmias which likely precipitated 
into lethal arrhythmias and contributed to the post-op mortality. Spontaneous ventricular tachyarrhythmias 
became less frequent over time and were rarely sighted one week post-surgery. However a degree of arrhythmo-
genicity remained after 4 weeks post-ablation, as evidenced by the non-sustained and sustained VT/VF induced 
with PES. The severe ventricular bradycardia in the CAVB rats led to an immediate increase in the stroke volume 
(Fig. 5G), likely to compensate for reduced cardiac output1,36. Echocardiograms revealed structural remodeling 
of the left ventricle over 4 weeks; end diastolic and systolic volumes progressively increased over 4 weeks, leading 
to >2-fold increase in the LV mass. Interestingly, fractional shortening and the ejection fraction increased during 
the first week post-surgery, but returned to near baseline levels at 4 weeks post-surgery. Noting that congestive 
heart failure develops in dogs with chronic CAVB37, it is plausible that our rat model of chronic CAVB may also 
develop congestive heart failure with preserved ejection fraction38. This warrants further investigation.
We and others have previously presented gene- and/or cell-based ventricular pacing as alternatives to elec-
tronic pacing devices for patients suffering from symptomatic ventricular bradycardia12,27,39,40. Motivation for 
hardware-free cardiac pacing goes beyond adult populations with device-related complications41,42. Current 
device-based cardiac pacing is incompatible for pediatric patients with congenital heart defects who are small yet 
growing, and the incidence of complications due to indwelling hardware are increasing43–45. Although we have 
demonstrated proof-of-principle for biological cardiac pacing, previous small animal models were limited to brief 
heart block caused by pharmacologic suppression of the cardiac conduction system. We took advantage of our 
rat model of chronic CAVB to test gene-based cardiac pacing by focal delivery of an adenoviral vector expressing 
TBX18 to the left ventricular apex of the rat heart one week after creating the CAVB. Re-expression of TBX18, 
a transcription factor that is essential for proper embryonic development of the SAN46,47, induces automaticity 
in postnatal ventricular cardiomyocytes in vitro and ventricular pacing in vivo12,27. Analysis of their ambulatory 
ECG over a 2 week period revealed that a ventricular rate >200 bpm emerged by day 7 post-gene delivery in 
TBX18-injected animals, which was distinct from and faster than the slow junctional rhythm (Fig. 6C). To visu-
alize this distinct beating pattern, beat-beat heart rate histograms revealed a bimodal distribution of heart rates 
in the TBX18 animals, indicative of two competing pacing sites (Fig. 6D). These data indicate that TBX18 creates 
a new ventricular pacing site which begins to compete with the native junctional rhythm in the same animal.
Taken together, the rat model of chronic CAVB presented here is conducive to gaining mechanistic insights 
into severe ventricular bradycardia and its subsequent degenerative processes. It also offers new opportunities for 
developing therapeutic modalities for mitigating the disease in a small animal model. Particularly, future studies 
on biological pacemakers can now quantitatively assess their robustness, longevity, autonomic regulation and 
arrhythmogenic risks in ambulatory rodents with chronic CAVB.
Methods
All surgical procedures and animal care protocols were in adherence and approval of the IACUC of the Emory 
University School of Medicine.
surgical procedures. Sprague Dawley rats (Charles River Laboratories International, Inc., Wilmington, MA) 
were anesthetized in an induction chamber with 5% isoflurane in 100% oxygen at a constant flow rate of 2 L/min 
for 6 minutes. Endotracheal intubation was performed with a 14-gauge, 57 mm long intravenous catheter. The 
animals were ventilated with a respirator (model 683, Harvard Apparatus, South Natick, MA) at 85 respirations 
per minute with a 2.5 ml stroke volume. Anesthesia was maintained in 2% isoflurane mixed with 100% oxygen 
throughout the surgery. Sterile lubricating eye ointment (LubriFreshTM P.M., MAJOR® Pharmaceuticals, Livonia, 
MI) was applied following induction of anesthesia to prevent corneal drying. Monopolar electrosurgical current 
was delivered to the AVN region via an active electrode connected to a high frequency electrosurgical generator 
in a coagulation mode (Aaron 950, Bovie Medical, Clearwater, FL). A reusable dispersive grounding pad elec-
trode (DRE Veterinary, Louisville, KY), serving as the return electrode, was placed on the back of the rat. The 
injection. One rat exhibited VT and another rat showed non-sustained VT upon PES with isoproterenol injection. 
Raw traces of PES-non-induced CAVB (top), and PES with isoproterenol-induced VF (bottom) are shown (N).
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Figure 6. Focal TBX18 gene transfer to the left ventricular apex of CAVB rats creates ventricular pacing that 
is faster than the slow junctional rate. (A) Timeline of the study indicating creation of CAVB and confirmation 
of chronic and stable CAVB for 7 days, second thoracotomy and focal injection of Adeno-TBX18 at the left 
ventricular apex, and a 14-day recording of ECG telemetry. (B) Mean heart rates over 2 weeks of TBX18- or 
GFP-injected animals. Shaded areas indicate the standard deviation of the heart rate at each time point.  
(C) Surface ECGs from GFP- (top) or TBX18-injected rat (middle) obtained at the time of and 2 weeks after 
gene delivery. TBX18-injected animals often exhibited two competing ventricular rhythms, one presumably 
from the slow junctional rhythm (arrowhead) and the other due to TBX18-injection (arrows). (D) Heart rate 
histograms of TBX18-injected animals show that a second major peak emerges 7 days post gene delivery, which 
is faster than the slow junctional rhythm. (E) Cardiac axis mapping of GFP-injected (left) and TBX18-injected 
(right) rats at 7 days post-injection. The faster ventricular rhythm in TBX18-injected animals exhibits QRS axis 
change and wider QRS complexes, which indicate retrograde conduction and myocardial depolarization that 
propagated without the ventricular conduction system, respectively.
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back of the rat was shaved to minimize electrical resistance between the animal and grounding pad. We found 
that a larger surface area grounding pad reduced the resistance and increased electrical current, thereby reducing 
the voltage necessary to achieve the same delivered power. Smaller ground pads or poor contact between the 
skin and the return electrode significantly reduced the effectiveness of AVN ablation and generated excessive 
heat at the skin-ground pad contact site, leading to severe skin burns. In order to ensure a sufficient skin-ground 
pad interface, we found that application of ultrasound electrode gel between the skin and ground pad signifi-
cantly increased the effectiveness of electrosurgical AVN ablation. During surgery, body temperature was main-
tained at 37 °C with a water blanket (T/Pump Professional, Stryker, Kalamazoo, MI). Carprofen (5 mg/kg) and 
Buprenorphine SR (1 mg/kg) were given subcutaneously for analgesia. Atropine (0.05 mg/kg) was given intra-
muscularly to reduce pulmonary secretion. Upon ablation of the AVN, the thoracic cage was repaired with a 4-0 
polyglycolic acid absorbable suture (SJ496G, McKESSON, Alpharetta, GA) and the lungs were fully inflated for 
two seconds to avoid pneumothorax immediately before closing the thoracic cavity. External thoracic muscles 
were repaired layer by layer with 4-0 absorbable suture. Skin was sutured with 4-0 monofilament polypropylene 
non-absorbable suture (P8683-SP, MYCO medical, Apex, NC). The isoflurane ventilation was reduced to zero 
after completion of the surgery. Once spontaneous breathing was evident, the endotracheal tube was removed. If 
excessive blood loss occurred (>2 mL), 2 mL of 0.9% sodium chloride solution was administered subcutaneously. 
Carprofen (5 mg/kg) was administered subcutaneously as a post-surgical analgesic at 24, 48, and 72 hours after 
surgery.
sham control group. Five Sprague Dawley rats underwent sham operation. Baseline echocardiogram was 
performed one day before sham operation. Sham operation was identical to CAVB surgery including right thor-
acotomy and advancing of the ablation needle into the AVN, but without delivering the electrosurgical energy. 
Echocardiogram and programmed electrical stimulation were performed at analogous time points as in CAVB rats.
Real-time recording of surface electrocardiograms and epicardial electrograms during AVN 
ablation. Biopolar, limb-lead surface electrocardiograms (ECG) were recorded on anesthetized animals with 
a BioAmp (FE135) signal amplifier, a PowerLab 8/35 digitizer and analyzed with LabChart Pro (ADInstruments, 
Colorado Springs, CO). Baseline ECGs were acquired just after intubation under anesthesia with 2% isoflurane. 
A partial right thoracotomy was performed in the third intercostal space to expose the right atrium and aorta. 
After retracting the thymus and removing pericardium, the right atrial appendage was partially ligated and the 
right atrium laterally retracted so as to avoid excessive tissue damage or bleeding during ablation. This maneuver 
exposed the epicardial aspect of atrioventricular nodal area, landmarked by the characteristic fat pad consistently 
located between the aortic root and the medial wall of the right atrium. The negative electrode for lead II was 
replaced with the electrode connected to the ablation needle for epicardial electrogram. This was achieved by 
attaching the electrode of a surface ECG cable (MLA1203, ADInstrument) to the proximal end of a 0.3 mm diam-
eter, 5 cm long ablation needle (DB106, DongBang Acupuncture, Korea, Fig. 1A) and insulating them together 
with polytetrafluoroethylene tape. 3 mm from the distal end (sharp end) were left exposed and bent at a 90 degree 
angle. Advancing the distal end of the ablation needle into the AVN region allowed real-time monitoring of sub-
epicardial electrogram at the ablation site. The ablation needle, in contact with the ECG electrode, was painted 
with a liquid electrical tape (LTB-400, Gardner Bender, Menomonee Falls, WI) for electrical insulation, exposing 
only the sharp, distal 3–4 mm end of the needle (Fig. 1B,C). Three factors significantly improved the post-op sur-
vival rate during the initial model creation stage: (i) minimizing myocardial damage and blood loss, (ii) relieving 
lung congestion during the recovery period of the surgery, and (iii) minimizing the number of ablation attempts 
to achieve CAVB. To avoid unintended damage of the surrounding myocardium during the electrosurgical energy 
delivery, the needle shaft was wrapped with an insulating tape exposing only the needle tip. The fine-tipped abla-
tion needle also allowed a partial right thoracotomy rather than midline/median sternotomy which is associated 
with high mortality and morbidity post-op20,21,48,49. We observed increased airway resistance in the CAVB animals 
during the recovery period likely due to excessive pulmonary secretion caused by the sudden drop in cardiac out-
put. Suppressing pulmonary acute mucous secretion with atropine as described above improved post-op survival 
rate of the CAVB rats during the initial model creation stage.
Telemetry recording of ECGs in ambulatory animals with CAVB. Ambulatory ECGs were recorded 
continuously by implanting a dual-lead, biopotential telemeter (TR50BB, Millar Inc., Houston, TX) in the 
abdominal cavity according to the manufacturer’s instructions. Lead I was obtained by positioning the electrodes 
on the left and right latissimus dorsi muscles. Lead II was obtained by positioning the electrodes between the 
suprasternal fossi and left lower thoracic cage. The electrical signals were transmitted to SmartPad (TR181, Millar 
Inc., Houston, TX) and analyzed with LabChart Pro (ADInstruments, Colorado Springs, CO).
echocardiographic evaluation of CAVB rats. Echocardiography was performed immediately before 
the surgery, then serially at one week and one month post-surgery with Vevo 2100 High Frequency ultrasound 
imaging system (VisualSonics, Toronto, Ontario) and analyzed with Vevo Imaging Workstation. Inter-ventricular 
septal thickness (IVS), LV posterior wall thickness (LVPW), and LV internal diameter (LVID) were measured 
in short axis during systolic and diastolic phases on M mode imaging. From these measurements, LV end dias-
tolic volume (LVEDV), LV end systolic volume (LVESV), LV fractional shortening (LVFS), LV ejection fraction 
(LVEF), and approximated LV myocardium mass were calculated.
Arrhythmia induction by programmed electrical stimulation combined with pharmacologic 
challenge. Ventricular arrhythmias were induced on five CAVB rats one month after CAVB creation. 
Animals were anesthetized with 5% isoflurane and placed on a mechanical ventilator after intubation. Anesthesia 
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was maintained with 2% isoflurane during programmed electrical stimulation (PES). The right jugular vein of 
the anesthetized CAVB rat was cannulated with a 21-gauge polyethylene tubing which was navigated into the 
right ventricle. Using the polyethylene tubing as a guide sheath, a platinum wire was inserted through the lumen 
of the tubing into the right ventricular cavity until ventricular electrical potentials could be detected. PES was 
performed with current stimulus isolator (FE180, ADInstruments, Colorado Springs, CO) with or without iso-
proterenol (5 mg/kg, ip) following our previous protocol29. Pacing thresholds were determined, and stimulation 
was delivered at a 1 ms pulse width at twice the capture threshold. An S1 drivetrain of 10 stimuli (100 ms interval) 
was applied followed by an extra stimulus (S2) starting at a coupling interval of 80 ms and by 1 ms decrements 
until the effective refractory period was reached. Another extra stimulus (S3) followed S2, decremented by 1 ms 
until the ventricular effective refractory period was reached. After this, a train of programmed stimulation with 
three extra stimuli after S1 (S2–S4) was performed until a ventricular arrhythmia was induced. If the rat failed to 
develop ventricular arrhythmia with 3 extra stimuli (S1–S4), the animal was deemed non-inducible.
Histopathology. The heart from seventeen rats were harvested, fixed in 10% formalin for 24 hours and 
paraffin-embedded for histopathological examination of the AVN region. The animals were grouped as follows: 
3-month old normal male (n = 3), 3-month old normal female (n = 3), 6-month old normal female (n = 3), 
6-month old normal male (n = 3) and 6-month old female with CAVB (n = 5). The paraffin-embedded tissue 
samples were sectioned at 5 µm thickness. Masson’s trichrome staining was performed to examine the native AVN 
structure and subsequent tissue necrosis post-electrosurgical energy delivery. Staining was performed according 
to manufacturer’s protocol (Masson’s Trichrome Staining Kit #KTMTR, American MasterTech, Inc., Lodi, CA). 
Stained sections were scanned with Hamamatsu Nanozoomer (Hamamatsu Photonics K.K., Japan). We measured 
the fibrotic area from upper margin of IVS to lower margin of IAS including the annulus ring of the mitral valve. 
The mitral valve leaflet was not included. Fibrotic area was measured by manually drawing a region of interest 
(ROI) around the circumference of blue collagen tissue. ROI area was measured using NDP.view2 software.
Direct injection of TBX18 into the left ventricular apex of CAVB rat in vivo. Upon creating CAVB, 
the animals were allowed to recover from the right thoracotomy and monitored for one week to confirm stable 
CAVB. Upon validating stable CAVB, the animals underwent a partial left thoracotomy in the fourth intercostal 
space to deliver an adenoviral vector expressing either TBX18-IRES-zsGreen1 (n = 4) or GFP (n = 4) to the heart. 
For each animal, 1 × 108 fluorescence forming units (ffu) of the adenoviral vector was injected in 100 µl of volume 
into the left ventricular apex of the heart. A telemetry device was implanted immediately after injection of the 
viral vector.
statistics. All data are expressed as mean ± standard deviation (SD) at a 95% confidence limit. For longitu-
dinal comparison of continuous variables such as mean heart rates, weight, and echocardiographic parameters, 
the statistical significance was tested using repeated-measures ANOVA with subsequent Bonferroni multiple 
comparisons test. Statistical analysis was performed using SPSS version 23.0 (IBM, Chicago, IL).
Data Availability
We will make available complete protocols for instrumentation of the surgery as well as the surgery protocol itself 
without undue qualifications in the MTAs. All published data will be shared promptly. The rodents harboring 
complete atrioventricular block generated from the disclosed surgical protocol are not transferrable due to the 
material and personnel expenses that are associated in creating the animal model.
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